Home / World Marketplace / Archive by category Global Health & Biotech (Page 42)

Archive by category Global Health & Biotech

Invitation – 2024 Financial Results Conference of Ascom Holding AG

Dear Ladies and Gentlemen We cordially invite you to the 2024 Financial Results Media Conference of Ascom Holding AG, for media representatives and analysts, which will take place as follows: Date: Wednesday, March 12, 2025 Time: 10:00 a.m. to approx. 11:30 a.m. CET Location: METROPOL, Fraumünsterstrasse 12, 8001 Zurich, Metropol Location & Contact. Room: Big Hall (ground floor) Registration: info@ascom.com. We kindly ask you to [...]

Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration

VANCOUVER, British Columbia, Feb. 26, 2025 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME) a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced achievement of a $14 million cash research milestone from GSK associated with a [...]

MROpenEVO at ECR 2025 with an AI-ready upgrade for further enhanced image quality and faster examinations; new system soon available in Georgia

A Media Snippet accompanying this announcement is available by clicking on this link. GENOA, Italy, Feb. 26, 2025 (Korea Bizwire) – Unlocking the future of joint and spine imaging with the Latest Evolution of MROpenEvo: the only truly open MRI System at ECR 2025. Thanks to the optimization of key technical features, the latest version [...]

OMass Therapeutics appoints Birgitte Volck as Non-Executive Director

OMass Therapeutics appoints Birgitte Volck as Non-Executive Director Oxford, United Kingdom – 26 February 2025 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ecosystems such as membrane proteins or intracellular complexes, today announces that Birgitte Volck MD, PhD has joined its Board as a non-executive director. Dr Volck [...]

ResMed’s Fifth Annual Global Sleep Survey Reveals a World Struggling with Poor Sleep

New insights from 30,026 people across 13 markets show the global scale of poor sleep and its impact on health, work, and relationships 7 out of 10 employed respondents have called in sick at least once in their career due to poor sleep. 18% of couples reported sleeping in separate rooms due to snoring and [...]

Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY(R) (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder

UZEDY is currently approved in the US as a subcutaneous long-acting injectable (LAI) for use every one or two months for the treatment of schizophrenia in adults1 LAI treatment options may help address unmet needs of people living with bipolar I disorder (BP-I) BP-I filing acceptance for UZEDY represents Teva’s commitment to pursuing new advances [...]

Zymeworks Announces Participation in Upcoming Investor Conferences

VANCOUVER, British Columbia, Feb. 25, 2025 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that management will participate in the following upcoming investor conferences: TD Cowen 45th Annual [...]

iHerb Surpasses $2.4 Billion in Sales, Solidifying Leadership in Global Health and Wellness

Company celebrates record-breaking year with 37 million orders fulfilled in 2024 IRVINE, Calif., Feb. 24, 2025 (Korea Bizwire) – iHerb, one of the world’s leading online retailers for vitamins, minerals, supplements and other health and wellness products, celebrated an extraordinary year in 2024, achieving over $2.4 billion in net sales, an all-time high for the company. [...]

Boehringer Ingelheim launches new trivalent poultry vaccine, includes protection against H5 avian influenza

VAXXITEK® HVT+IBD+H5 is a new trivalent vaccine for poultry that offers protection against Marek’s disease, Infectious Bursal Disease and H5 avian influenza in just one shot. H5 avian influenza is a highly contagious and notifiable zoonotic disease, that is currently having a heavy impact on the poultry industry, farmers, and international trade worldwide. Administration at the [...]

Sandoz launches biosimilar Pyzchiva® (ustekinumab-ttwe) in the US, offering new treatment for around 12 million patients[1-4]

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Key biosimilar value driver contributes to Sandoz global growth strategy and moves company closer to becoming #1 in biosimilars in US Strengthens US immunology portfolio and increases access to biologics for patients suffering from chronic inflammatory diseases, such as psoriasis and psoriatic arthritis [...]